By admin | Published:
March 16, 2008
March 16, 2008
Robert Pirker
ROBERT PIRKER , Medical University of Vienna
Phase III study results have detected improvements in overall survival among patients with advanced non-small cell lung cancer treated with a monoclonal antibody targeted to the epidermal growth factor receptor: EGFR. Robert Pirker told the Turin congress he thinks is an emerging role for EGRF-targeted antibodies in lung cancer for patients who test positive for the epidermal growth factor receptor. He discussed the data with Peter Goodwin.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Posted in News | Tagged cancer, cetuximab, improvements, lung, medication, monoclonal, patient, receptor, study, survival, test |
By admin | Published:
March 16, 2008
March 16, 2008
Ugo Pastorino
UGO PASTORINO , Istituto Nazionale Tumori, Milan
Even the most sophisticated and powerful detection method for lung cancer detection, spiral CT, is still unproven in the context of mass screening for lung cancer. At the conference in Turin, Ugo Pastorino, urged delegates to wait for the findings of the large randomized studies of spiral CT now being conducted before deciding whether to use this technique. He discussed his group’s findings with Peter Goodwin.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
February 26, 2008
February 26, 2008
Martin Dreyling
Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
MARTIN DREYLING, University Hospital Grosshaden, Munich
Since the 1970s therapies for mantle cell lymphoma have greatly extended life, Martin Dreyling told conference delegates in Paris. He gave Peter Goodwin his latest data on combination therapy using the antibody, rituximab, and the emerging rôles of other targeted agents.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
February 26, 2008
February 26, 2008
John Gribben
Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
JOHN GRIBBEN, Bartholemews Hospital, London
New promise for treating chronic lymphocytic leukemia is arising from combining antibody therapies rituximab and alemtuzumab with new drugs such as lenalidomide alongside standard fludarabine therapy. At the Paris symposium John Gribben gave Peter Goodwin the latest details.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
January 27, 2008
January 27, 2008
Eugene Schiff
REFERENCE: General Session IV
EUGENE SCHIFF, University of Miami
Screening for Hepatitits C and B, and subsequent screening for cancer, can save millions of lives from hepatocellular carcinoma. Eugene Schiff told the Gastrointestinal Cancers Conference in Orlando which populations are most at risk. He discussed his data with Peter Goodwin.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
January 26, 2008
January 26, 2008
William Blot
REFERENCE: General Session 1: Cancers of the Esophagus and Stomach
WILLIAM BLOT, Vanderbilt University, Nashville TN
Obesity emerged as a key cause of esophageal cancer from data presented by William Blot who told Peter Goodwin about the changing pattern of both esophageal and stomach cancer throughout the world, and about the likely ways of preventing them.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
January 8, 2008
January 8, 2008
Richard Peto
REFERENCE: Lancet 371:29-40; January 5, 2008
RICHARD PETO, Oxford University
The prospect of cutting breast cancer mortality in half throughout the world is held out by Richard Peto of the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). He talks with Peter Goodwin following the group’s most recent publication in The Lancet.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Buy + Download Now This Interview
Posted in News | Tagged breast, cancer, chemotherapy, collaborative group, findings, iphone, lancet, mortality, Oncology, oxford university, peter goodwin, podcast, podcasting, prospects, richard peto |
By admin | Published:
December 14, 2007
December 14, 2007
Margaret Foti
MARGARET FOTI, American Association for Cancer Research, Philadelphia
The San Antonio Breast Cancer Symposium will, in the future, be presented jointly by the Cancer Therapy and Research Center at the University of Texas Health Science Center, Baylor College of Medicine, and the American Association for Cancer Research. Peter Goodwin found out more on this new collaboration from Margaret Foti, CEO of the American Association for Cancer Research in Philadelphia.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Posted in News | Tagged aacr, antonio breast cancer symposium, baylor college of medicine, breast cancer symposium, breast-cancer, cancer research, cancer therapy, college of medicine, foti, health science center, iphone, margeret, Oncology, peter goodwin, san antonio breast, san antonio breast cancer, san antonio breast cancer symposium, texas health science, texas health science center, university of texas health science center |
